Oganesyan Oganes Georgievich, Gusak Daria Alexandrovna, Saakyan Svetlana Vladimirovna, Amiryan Anush Gamletovna, Milash Sergey Victorovich, Oganesyan Carolina
Department of Ophthalmology, Crystal Vision Bahrаin Specialist Hospital, Manama, Bahrain.
Department of Ophthalmic Oncology and Radiology, Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russian Federation.
Am J Ophthalmol Case Rep. 2025 Jun 27;39:102372. doi: 10.1016/j.ajoc.2025.102372. eCollection 2025 Sep.
Herein, we report a rare case of recurrent hematocornea due to a non-pigmented adenoma of the ciliary body and its successful management with repeated deep anterior lamellar keratoplasty (DALK).
A 27-year-old man presented with significant visual acuity loss in his only functional eye due to hematocornea. Initial management involved visco-DALK, which restored visual acuity to 0.8. After 6 months, recurrent hematocornea prompted the removal of the underlying neoplasm through a scleral approach, which was histologically confirmed as a non-pigmented adenoma of the ciliary body. A repeat DALK was performed, followed by phacoemulsification with intraocular lens implantation for subsequent cataract development. Postoperative recovery was uneventful, and visual acuity stabilized at 0.8.
This case highlights the feasibility and efficacy of visco-DALK in managing hematocornea while preserving endothelial integrity. The approach facilitated subsequent interventions, including neoplasm excision, repeat DALK, and cataract surgery, with favorable visual outcomes.
在此,我们报告一例罕见的因睫状体无色素腺瘤导致的复发性角膜积血病例,以及通过重复的前板层角膜移植术(DALK)成功治疗的情况。
一名27岁男性因角膜积血导致其仅有的一只功能眼中视力严重下降。初始治疗采用黏性DALK,视力恢复至0.8。6个月后,复发性角膜积血促使通过巩膜入路切除潜在肿瘤,组织学检查证实为睫状体无色素腺瘤。再次进行DALK,随后因白内障发展进行超声乳化白内障吸除联合人工晶状体植入术。术后恢复顺利,视力稳定在0.8。
本病例突出了黏性DALK在治疗角膜积血同时保留内皮完整性方面的可行性和有效性。该方法便于后续干预,包括肿瘤切除、重复DALK和白内障手术,并取得了良好的视力结果。